Literature DB >> 28176137

SMARCA4-deficient Sinonasal Carcinoma.

Abbas Agaimy1, Wilko Weichert2,3,4.   

Abstract

The term "sinonasal undifferentiated carcinoma (SNUC)" has been coined in 1986 for a highly aggressive sinonasal tract epithelial neoplasm showing distinctive morphology, but lacking any specific line of differentiation. Recent developments resulted in a dynamic splitting of new entities traditionally included in the spectrum of SNUC. Sinonasal NUT-midline carcinoma, adamantinoma-like Ewing family tumors and most recently, SMARCB1(INI1)-deficient sinonasal carcinoma are the main entities defined by specific genetic aberrations. To our knowledge, involvement of subunits of the SWItch/Sucrose Non-fermentable (SWI/SNF) chromatin remodeling complex other than SMARCB1 has not been implicated in the pathogenesis of SNUC-like neoplasms. We herein describe a 40-year-old woman who presented with a large infiltrative mass involving the right nasal cavity and the sinuses with extension into the skull base and periorbital tissue (cT4N2M0). Biopsies were interpreted initially as poorly differentiated neuroendocrine carcinoma followed by surgical resection and radiochemotherapy. No other extra-nasal tumor was detected on imaging. The patient was alive with disease at last follow-up (9 months from initial diagnosis). Histological evaluation showed poorly differentiated small round blue cell neoplasm with diffuse expression of pancytokeratin but not high molecular weight cytokeratin subsets, CK7, p63, S100, desmin or NUT. Neuroendocrine markers showed limited focal weak reactivity. SMARCB1, SMARCA2 and ARID1A were intact in the tumor cells but SMARCA4 was completely lost. This case highlights the rare occurrence of SMARCA4-deficiency in poorly differentiated sinonasal carcinomas and points to the importance of including other SWI/SNF complex subunits in the evaluation of SMARCB1-intact sinonasal malignancies.

Entities:  

Keywords:  NUT midline carcinoma; SMARCA4; SMARCB1-deficient carcinoma; SNUC; Sinonasal tract; Small round cell tumor

Mesh:

Substances:

Year:  2017        PMID: 28176137      PMCID: PMC5677070          DOI: 10.1007/s12105-017-0783-4

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  22 in total

1.  Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

Authors:  Petar Jelinic; Jennifer J Mueller; Narciso Olvera; Fanny Dao; Sasinya N Scott; Ronak Shah; JianJiong Gao; Nikolaus Schultz; Mithat Gonen; Robert A Soslow; Michael F Berger; Douglas A Levine
Journal:  Nat Genet       Date:  2014-03-23       Impact factor: 38.330

Review 2.  The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity.

Authors:  Abbas Agaimy
Journal:  Adv Anat Pathol       Date:  2014-11       Impact factor: 3.875

3.  SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens.

Authors:  Esther Herpel; Ralf J Rieker; Hendrik Dienemann; Thomas Muley; Michael Meister; Arndt Hartmann; Arne Warth; Abbas Agaimy
Journal:  Ann Diagn Pathol       Date:  2016-10-20       Impact factor: 2.090

4.  Large Cell Neuroendocrine Carcinoma of the Head and Neck: A Clinicopathologic Series of 10 Cases With an Emphasis on HPV Status.

Authors:  Elizabeth D Thompson; Edward B Stelow; Stacey E Mills; William H Westra; Justin A Bishop
Journal:  Am J Surg Pathol       Date:  2016-04       Impact factor: 6.394

Review 5.  "Undifferentiated" neoplasms of the sinonasal region: differential diagnosis based on clinical, light microscopic, immunohistochemical, and ultrastructural features.

Authors:  S E Mills; R E Fechner
Journal:  Semin Diagn Pathol       Date:  1989-11       Impact factor: 3.464

6.  NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract.

Authors:  Edward B Stelow; Andrew M Bellizzi; Krishan Taneja; Stacey E Mills; Robin D Legallo; Jeffery L Kutok; Jon C Aster; Christopher A French
Journal:  Am J Surg Pathol       Date:  2008-06       Impact factor: 6.394

Review 7.  Undifferentiated malignant neoplasms of the sinonasal tract.

Authors:  Bruce M Wenig
Journal:  Arch Pathol Lab Med       Date:  2009-05       Impact factor: 5.534

8.  Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from schneiderian epithelium and distinct from olfactory neuroblastoma.

Authors:  H F Frierson; S E Mills; R E Fechner; J B Taxy; P A Levine
Journal:  Am J Surg Pathol       Date:  1986-11       Impact factor: 6.394

9.  Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma.

Authors:  Vickie Y Jo; Nicole G Chau; Jason L Hornick; Jeffrey F Krane; Lynette M Sholl
Journal:  Mod Pathol       Date:  2017-01-13       Impact factor: 8.209

10.  SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms.

Authors:  Abbas Agaimy; Michael Koch; Michael Lell; Sabine Semrau; Wojciech Dudek; David L Wachter; Antje Knöll; Heinrich Iro; Florian Haller; Arndt Hartmann
Journal:  Am J Surg Pathol       Date:  2014-09       Impact factor: 6.394

View more
  10 in total

Review 1.  High-Grade Sinonasal Carcinoma: Classification Through Molecular Profiling.

Authors:  Julie Guilmette; Peter M Sadow
Journal:  Arch Pathol Lab Med       Date:  2019-02-19       Impact factor: 5.534

2.  Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities.

Authors:  Krystal A Orlando; Vinh Nguyen; Jesse R Raab; Tara Walhart; Bernard E Weissman
Journal:  Expert Rev Anticancer Ther       Date:  2019-05-13       Impact factor: 4.512

3.  Does Reorganization of Clinicopathological Information Improve Prognostic Stratification and Prediction of Chemoradiosensitivity in Sinonasal Carcinomas? A Retrospective Study on 145 Patients.

Authors:  Marco Ferrari; Davide Mattavelli; Alberto Schreiber; Tommaso Gualtieri; Vittorio Rampinelli; Michele Tomasoni; Stefano Taboni; Laura Ardighieri; Simonetta Battocchio; Anna Bozzola; Marco Ravanelli; Roberto Maroldi; Cesare Piazza; Paolo Bossi; Alberto Deganello; Piero Nicolai
Journal:  Front Oncol       Date:  2022-06-03       Impact factor: 5.738

Review 4.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Nasal Cavity, Paranasal Sinuses and Skull Base.

Authors:  Lester D R Thompson; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2022-03-21

5.  Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: SWI/SNF-deficient Sinonasal Neoplasms: An Overview.

Authors:  Abbas Agaimy
Journal:  Head Neck Pathol       Date:  2022-03-21

Review 6.  [Diagnostic and predictive molecular pathology of head and neck neoplasms].

Authors:  A Agaimy; W Weichert; F Haller; A Hartmann
Journal:  Pathologe       Date:  2018-02       Impact factor: 1.011

Review 7.  Novel Biomarkers in Sinonasal Cancers: from Bench to Bedside.

Authors:  Matt Lechner; Jacklyn Liu; Valerie J Lund
Journal:  Curr Oncol Rep       Date:  2020-07-29       Impact factor: 5.075

8.  A rare presentation of Sinonasal Undifferentiated Carcinoma with brain metastasis and para-aortic mass.

Authors:  Sujata Sarangi; Sudeep Khera; Vikarn Vishwajeet; Vikas Meshram; Puneet Setia; Abhishek Malik
Journal:  Autops Case Rep       Date:  2020-11-20

Review 9.  SMARCB1/INI1 Deficient Sino-Nasal Carcinoma: Extending the Histomorphological Features.

Authors:  Pavithra Ayyanar; Pritinanda Mishra; Chappity Preetam; Amit Kumar Adhya
Journal:  Head Neck Pathol       Date:  2020-11-03

10.  Fine needle biopsy of malignant tumors of the liver: a retrospective study of 624 cases from a single institution experience.

Authors:  Lin Zhang; Zhenjian Cai; Joe Rodriguez; Songlin Zhang; Jaiyeola Thomas; Hui Zhu
Journal:  Diagn Pathol       Date:  2020-05-06       Impact factor: 2.644

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.